J&J Alters Plans for Surgical Robotics Platform

J&J Alters Plans for Surgical Robotics Platform

Source: 
Medical Devices and Diagnostics Industry
snippet: 

The New Brunswick, NJ-based company won’t pursue a 510(k) pathway for the platform and will have first-in-human studies in the late half of 2022.